Download free PDF

Intravenous Equipment Market Size & Share 2023 to 2032

Market Size by Product (IV Catheters, Administration Sets, Infusion Pumps, Securement Devices, Drip Chambers, Stopcocks and Check Valves, Needless Connectors).

Report ID: GMI4017
   |
Published Date: August 2023
 | 
Report Format: PDF

Download Free PDF

Intravenous Equipment Market Size

Intravenous Equipment Market size was valued at USD 14.4 billion in 2022 and is estimated to account for USD 27.2 billion by 2032. Intravenous (IV) equipment refers to the devices, instruments, and supplies used in intravenous therapy. It includes a range of products such as IV catheters, intravenous infusion pumps, IV sets, connectors, and accessories.

Intravenous Equipment Market Key Takeaways

Market Size & Growth

  • 2022 Market Size: USD 14.3 Billion
  • 2032 Forecast Market Size: USD 27.2 Billion
  • CAGR (2023โ€“2032): 6.7%

Key Market Drivers

  • Increasing demand for ambulatory infusion pumps.
  • Rising prevalence of chronic disease.
  • High surge in surgical procedures.
  • Technological advancements regarding IV equipment.

Challenges

  • Medical errors associated with IV equipment.
  • Stringent regulatory framework.

IV equipment is specifically designed to facilitate the administration of fluids, medications, or nutrients directly into the patient's veins. This method allows for rapid and controlled delivery of substances into the bloodstream, ensuring efficient absorption and distribution throughout the body. IV equipment plays a critical role in healthcare settings, enabling healthcare professionals to deliver essential treatments and therapies effectively. Key factors driving the industry expansion include the rising prevalence of chronic diseases, technological advancements in novel drug delivery systems, increasing healthcare expenditure, and the demand for efficient patient care.
 

Surgical procedures often necessitate the use of intravenous therapy for various purposes, including fluid replacement, anesthesia administration, and post-operative pain management. With the rising number of surgeries being performed globally, there is a corresponding increase in the demand for IV equipment. Hospitals and healthcare facilities require a reliable supply of IV catheters, infusion pumps, and related equipment to support safe and efficient perioperative care. For instance, according to the National Library of Medicine, which is part of the National Institutes of Health (NIH) reports that globally, there are approximately 310 million major surgeries performed annually, with 40 to 50 million taking place in the U.S. and 20 million in Europe. Studies indicate that a small percentage, ranging from 1 to 4% of these patients may experience mortality, while up to 15% may encounter significant postoperative morbidity. Furthermore, within 30 days following surgery, a percentage of patients, ranging from 5 to 15%, may necessitate readmission.
 

COVID-19 Impact

The COVID-19 pandemic had a positive impact on the intravenous equipment market. Increased hospitalizations and critical care needs of COVID-19 patients led to a higher demand for IV equipment, including infusion pumps, catheters, and IV sets. The need for intravenous medications specific to COVID-19 treatment further fuelled the market. Emphasis on infection control and the rise in home healthcare during the pandemic. The ongoing need for IV therapy, advancements in technology, and the trend towards home healthcare.
 

Intravenous Equipment Market

Intravenous Equipment Market Trends

Chronic diseases such as cancer, diabetes, cardiovascular disorders, and autoimmune conditions have become increasingly prevalent worldwide. For instance, according to the American Autoimmune Related Diseases Association (AARDA), there are over 100 identified autoimmune diseases, and they collectively affect more than 50 million people in the U.S. Furthermore, according to the International Agency for Research on Cancer (IARC) in December 2020, global estimates indicate that approximately 1 in 5 individuals will develop cancer at some point in their lifetime. IV equipment enables healthcare professionals to administer medications, fluids, and nutrients directly into the patient's veins, ensuring efficient and targeted delivery. The growing incidence of chronic diseases, coupled with the need for effective treatment.
 

Intravenous Equipment Market Analysis

 Intravenous (IV) Equipment Market Size, By Product, 2021 - 2032 (USD Billion)

The intravenous equipment market by product is categorized into IV catheters, administration sets, infusion pumps, securement devices, drip chambers, stopcocks and check valves, needless connectors, and others. The IV catheters segment garnered USD 3.3 billion revenue size in the year 2022. IV catheters are essential for administering fluids and medications directly into the patient's bloodstream during IV therapy. They find applications across various healthcare settings and specialties, making them a versatile and in-demand product. Furthermore, ongoing technological advancements in IV catheters aim to enhance patient comfort and safety, attracting healthcare providers. The rising prevalence of chronic diseases further fuels the demand for IV therapy and, consequently, IV catheters.
 

Intravenous Equipment Market Share, By End-use, 2022

Based on end-use, the intravenous equipment market is segmented into hospitals and clinics, diagnostic centers, ambulatory surgical centers, and others. The hospitals and clinics segment accounted for over 34% market share in the year 2022. Hospitals and clinics witness a high volume of IV procedures across diverse medical specialties, creating a sustained demand for IV equipment. With advanced healthcare infrastructure and a focus on patient safety, hospitals and clinics prioritize the use of innovative IV equipment to provide optimal care. For instance, according to the American Hospital Associationโ€™s (AHA) Hospital Statistics 2022 edition, the total number of patients admissions in all hospitals across the U.S. amounted to approximately 33.3 million.
 

U.S. Intravenous (IV) Equipment Market Size, 2020 -2032 (USD Billion)

U.S. intravenous equipment market accounted for USD 5.4 billion revenue size in 2022. Increasing geriatric population base along with the rising incidence of cancer in the country will drive the U.S. industry progression. For instance, according to the American Cancer Society, it is projected that in 2023, there will be approximately 2 million new cases of cancer and an estimated 609,820 cancer-related deaths in the U.S. Moreover, growing awareness regarding remote patient monitoring devices for improved accuracy, portability, connectivity, and user-friendly interface will boost market adoption rate.

 

Intravenous (IV) Equipment Market Share

Some of the eminent industry participants operating in the intravenous equipment market include

  • B. Braun Melsungen AG
  • 3M
  • Terumo Corporation
  • Abbott
  • Teleflex Incorporated
  • BD
  • Henry Schein, Inc.
  • Smiths Medical
  • Baxter
  • Ascor S.A.
  • Moog Inc.
  • AngioDynamics.
  • ICU Medical, Inc.
  • Fresenius SE & Co. KGaA
  • Animas LLC
  • Arcomed Ag
  • International WIN, LTD.
  • The Metrix Company 
     

Intravenous (IV) Equipment Industry News:

  • In May 2023, Terumo announced the establishment of a state-of-the-art manufacturing facility at its esteemed Kofu Factory. This strategic move by the Medical Care Solutions Company involved a substantial capital investment of USD 360 million.
     
  • In July 2022, B. Braun Medical Inc. introduced the Introcan Safety 2 IV catheter, including a one-time blood control mechanism. This advanced IV catheter enhances the safety of healthcare professionals by mitigating the potential for needlestick injuries and minimizing their exposure to blood during catheter insertion.
     

Intravenous equipment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

By Product (USD Million & Units)

  • IV catheters
  • Administration sets
  • Infusion pumps
  • Securement devices
  • Drip chambers
  • Stopcocks and check valves
  • Needless connectors
  • Others

By End-use (USD Million)

  • Hospitals and clinics
  • Diagnostic centers
  • Ambulatory surgical centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Switzerland
    • The Netherlands
    • Denmark
    • Poland
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • New Zealand
    • Thailand
    • Vietnam
    • Indonesia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Turkey
       
Authors:  Monali Tayade, Pratiksha Kamthe

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • โœ“ Key growth drivers and their assumed impact

    • โœ“ Restraining factors and mitigation scenarios

    • โœ“ Regulatory assumptions and policy change risk

    • โœ“ Technology adoption curve parameter

    • โœ“ Macroeconomic assumptions (GDP growth, inflation, currency)

    • โœ“ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • โœ“ Statistical Validation

    • โœ“ Expert Validation

    • โœ“ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
What is the intravenous equipment industry worth?
Intravenous (IV) equipment market size was USD 14.4 billion in 2022 and is estimated to reach USD 27.2 billion by 2032 driven by rising usage in healthcare setting for enabling healthcare professionals to deliver essential treatments and therapies effectively
How is the demand for IV equipment driven across hospitals and clinics?
The hospitals and clinics segment recorded over 34% of the market share in 2022 owing to the presence of advanced healthcare infrastructure and higher focus on patient safety ?
What is the value of the U.S. intravenous equipment market?
Demand for intravenous equipment in the U.S. reached USD 5.4 billion in 2022 and is predicted to witness substantial market growth through 2032 due to the expanding geriatric population base and the rising incidence of cancer in the country
Who are the key IV equipment industry players?
Some key intravenous equipment providers include B. Braun Melsungen AG, 3M, Terumo Corporation, Abbott, Teleflex Incorporated, BD, Henry Schein, Inc., Smiths Medical, Baxter, Ascor S.A., Moog Inc., AngioDynamics., ICU Medical, Inc., Fresenius SE & Co. KGaA, and Animas LLC
Intravenous Equipment Market Scope
  • Intravenous Equipment Market Size

  • Intravenous Equipment Market Trends

  • Intravenous Equipment Market Analysis

  • Intravenous Equipment Market Share

Authors:  Monali Tayade, Pratiksha Kamthe
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2022

Companies Profiled: 17

Tables & Figures: 288

Countries Covered: 30

Pages: 210

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)